Current and historical daily PE Ratio for Haisco Pharmaceutical Group Co Ltd (
) from 2012 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Haisco Pharmaceutical Group stock (SZSE:002653) PE ratio as of Jun 09 2024 is 94.91.
More Details
Haisco Pharmaceutical Group Co Ltd (SZSE:002653) PE Ratio (TTM) Chart
Haisco Pharmaceutical Group Co Ltd (SZSE:002653) PE Ratio (TTM) Historical Data
View and export this data going back to 2012. Start your Free Trial
Total 1201
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Haisco Pharmaceutical Group PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 94.9 | 2024-04-01 | 81.9 |
| 2024-06-07 | 94.9 | 2024-03-29 | 84.8 |
| 2024-06-06 | 97.6 | 2024-03-28 | 84.5 |
| 2024-06-05 | 96.3 | 2024-03-27 | 97.5 |
| 2024-06-04 | 95.6 | 2024-03-26 | 97.8 |
| 2024-06-03 | 94.2 | 2024-03-25 | 97.5 |
| 2024-05-31 | 95.8 | 2024-03-22 | 97.5 |
| 2024-05-30 | 95.9 | 2024-03-21 | 98.7 |
| 2024-05-29 | 98.0 | 2024-03-20 | 98.7 |
| 2024-05-28 | 94.1 | 2024-03-19 | 99.2 |
| 2024-05-27 | 94.7 | 2024-03-18 | 101.9 |
| 2024-05-24 | 93.3 | 2024-03-15 | 103.7 |
| 2024-05-23 | 94.4 | 2024-03-14 | 100.7 |
| 2024-05-22 | 95.7 | 2024-03-13 | 95.0 |
| 2024-05-21 | 96.5 | 2024-03-12 | 92.3 |
| 2024-05-20 | 96.4 | 2024-03-11 | 95.6 |
| 2024-05-17 | 98.1 | 2024-03-08 | 91.7 |
| 2024-05-16 | 95.7 | 2024-03-07 | 90.5 |
| 2024-05-15 | 96.3 | 2024-03-06 | 93.7 |
| 2024-05-14 | 94.4 | 2024-03-05 | 95.6 |
| 2024-05-13 | 94.4 | 2024-03-04 | 95.8 |
| 2024-05-10 | 95.7 | 2024-03-01 | 93.8 |
| 2024-05-09 | 96.3 | 2024-02-29 | 92.6 |
| 2024-05-08 | 94.1 | 2024-02-28 | 88.2 |
| 2024-05-07 | 95.7 | 2024-02-27 | 88.9 |
| 2024-05-06 | 97.7 | 2024-02-26 | 88.8 |
| 2024-04-30 | 94.9 | 2024-02-23 | 86.8 |
| 2024-04-29 | 93.5 | 2024-02-22 | 85.7 |
| 2024-04-26 | 89.0 | 2024-02-21 | 85.2 |
| 2024-04-25 | 88.1 | 2024-02-20 | 86.4 |
| 2024-04-24 | 85.3 | 2024-02-19 | 86.4 |
| 2024-04-23 | 84.1 | 2024-02-08 | 87.0 |
| 2024-04-22 | 82.5 | 2024-02-07 | 87.2 |
| 2024-04-19 | 81.0 | 2024-02-06 | 79.9 |
| 2024-04-18 | 79.4 | 2024-02-05 | 72.7 |
| 2024-04-17 | 85.0 | 2024-02-02 | 74.6 |
| 2024-04-16 | 82.6 | 2024-02-01 | 78.3 |
| 2024-04-15 | 84.8 | 2024-01-31 | 79.9 |
| 2024-04-12 | 83.5 | 2024-01-30 | 80.8 |
| 2024-04-11 | 83.8 | 2024-01-29 | 82.2 |
| 2024-04-10 | 82.5 | 2024-01-26 | 84.0 |
| 2024-04-09 | 83.8 | 2024-01-25 | 84.7 |
| 2024-04-08 | 83.1 | 2024-01-24 | 84.0 |
| 2024-04-03 | 82.5 | 2024-01-23 | 83.2 |
| 2024-04-02 | 81.8 | 2024-01-22 | 80.6 |
Haisco Pharmaceutical Group Co Ltd (SZSE:002653) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Haisco Pharmaceutical Group Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100001BC7
Share Class Description:
SZSE:002653: Class ACompare
Compare
Traded in other countries / regions
002653.China IPO Date
2012-01-17Description
Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers